U.S. Food and Drug Administration - CDRH Mobile
Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule

FDA > CDRH > Device Advice > 510(k) Submission Process > 510(k) Review Template

PDF Printer Version510(k) Review Template

Premarket Notification [510(k)] Review
Traditional/Abbreviated
K______________

Date:

To: The Record Office:
From: Division:

510(k) Holder:
Device Name:
Contact:
Phone:
Fax:
Email:

I. Purpose and Submission Summary

The 510(k) holder would like to introduce (device name) into interstate commerce.

II. Administrative Requirements

 

 

Yes

No

N/A

Indications for Use page (Indicate if: Prescription or OTC)

 

 

 

Truthful and Accuracy Statement

 

 

 

510(k) Summary or 510(k) Statement

 

 

 

Standards Form

 

 

 

III. Device Description

 

 

Yes

No

N/A

Is the device life-supporting or life sustaining?

 

 

 

Is the device an implant (implanted longer than 30 days)?

 

 

 

Does the device design use software?

 

 

 

Is the device sterile?

 

 

 

Is the device reusable (not reprocessed single use)?

Are “cleaning” instructions included for the end user?

 

 

 

IV. Indications for Use

V. Predicate Device Comparison

VI. Labeling

VII. Sterilization/Shelf Life/Reuse

VIII. Biocompatibility

IX. Software

Version:

Level of Concern:

 

Yes

No

Software description:

 

 

Device Hazard Analysis:

 

 

Software Requirements Specifications:

 

 

Architecture Design Chart:

 

 

Design Specifications:

Traceability Analysis/Matrix:

Development:

V&VT:

Revision level history:

Unresolved anomalies:

 

 

 

Traceability Analysis/Matrix:

 

 

 

Development:

 

 

 

Verification & Validation Testing:

 

 

 

Revision level history:

 

 

Unresolved anomalies:

 

 

 

X. Electromagnetic Compatibility and Electrical, Mechanical and Thermal Safety

XI. Performance Testing – Bench

XII. Performance Testing – Animal

XIII. Performance Testing – Clinical

XIV. Substantial Equivalence Discussion

 
Yes
No
  

1. Same Indication Statement?

 

 

If YES = Go To 3

2. Do Differences Alter The Effect Or Raise New Issues of Safety Or Effectiveness?

 

 

If YES = Stop NSE

3. Same Technological Characteristics?

 

 

If YES = Go To 5

4. Could The New Characteristics Affect Safety Or Effectiveness?

 

 

If YES = Go To 6

5. Descriptive Characteristics Precise Enough?

 

 

If NO = Go To 8

If YES = Stop SE

6. New Types Of Safety Or Effectiveness Questions?

 

 

If YES = Stop NSE

7. Accepted Scientific Methods Exist?

 

 

If NO = Stop NSE

8. Performance Data Available?

 

 

If NO = Request Data

9. Data Demonstrate Equivalence?

 

 

Final Decision:

Note: See the Flowchart to assist in decision-making process. Please complete the following table and answer the corresponding questions. "Yes" responses to questions 2, 4, 6, and 9, and every "no" response requires an explanation.

  1. Explain how the new indication differs from the predicate device's indication:
  2. Explain why there is or is not a new effect or safety or effectiveness issue:
  3. Describe the new technological characteristics:
  4. Explain how new characteristics could or could not affect safety or effectiveness:
  5. Explain how descriptive characteristics are not precise enough:
  6. Explain new types of safety or effectiveness question(s) raised or why the question(s) are not new:
  7. Explain why existing scientific methods can not be used:
  8. Explain what performance data is needed:
  9. Explain how the performance data demonstrates that the device is or is not substantially equivalent:

XV. Deficiencies
When developing deficiencies please consider the following “Suggested Format for Developing and Responding to Deficiencies in Accordance with the Least Burdensome Provisions of FDAMA” and “A Suggested Approach to Resolving Least Burdensome Issues”

XVI. Contact History

XVII. Recommendation
Regulation Number: 21 CFR XXX.XXXX [Only one regulation can be used.]
Regulation Name:
Regulatory Class: Class I, II, III, or Unclassified [Should correspond to regulation.]
Product Code: XYZ [Note: The first code should correspond with the regulation and class thereafter, multiple product codes can be used even if they fall under a different regulation and class.]

Reviewer Date

 

Branch Chief Date

Updated August 1, 2007

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH